Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Cristina Gervasoni and Giuliano Rizzardini.
Connection Strength

1.212
  1. Dolutegravir and metformin: a clinically relevant or just a pharmacokinetic interaction? AIDS. 2018 02 20; 32(4):532-533.
    View in: PubMed
    Score: 0.189
  2. Psychoactive drugs and HIV: are we sure to treat our patients adequately? AIDS. 2018 01 02; 32(1):127-128.
    View in: PubMed
    Score: 0.187
  3. Effect of Cobicistat on Tenofovir Disoproxil Fumarate (TDF): What Is True for TAF May Also Be True for TDF. J Acquir Immune Defic Syndr. 2018 01 01; 77(1):86-92.
    View in: PubMed
    Score: 0.187
  4. Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference. J Antimicrob Chemother. 2017 06 01; 72(6):1842-1844.
    View in: PubMed
    Score: 0.180
  5. How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life? J Acquir Immune Defic Syndr. 2017 05 01; 75(1):e24-e26.
    View in: PubMed
    Score: 0.179
  6. Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction. AIDS. 2017 03 27; 31(6):867-868.
    View in: PubMed
    Score: 0.177
  7. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427.
    View in: PubMed
    Score: 0.057
  8. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.